These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37851564)

  • 21. Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.
    Baumal CR; Goldberg RA; Fein JG
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):432-8. PubMed ID: 25970863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence.
    Hoyek S; Cruz NFSD; Patel NA; Al-Khersan H; Fan KC; Berrocal AM
    Prog Retin Eye Res; 2023 Nov; 97():101208. PubMed ID: 37611892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy.
    Kuo HK; Sun IT; Chung MY; Chen YH
    Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term retinal detachment risk after treatment of type 1 retinopathy of prematurity with laser photocoagulation versus intravitreal bevacizumab.
    Barry GP; Tauber KA; Fisher M; Greenberg S; Zobal-Ratner J; Binenbaum G
    J AAPOS; 2019 Oct; 23(5):260.e1-260.e4. PubMed ID: 31513902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter Validation of Deep Learning Algorithm ROP.AI for the Automated Diagnosis of Plus Disease in ROP.
    Bai A; Dai S; Hung J; Kirpalani A; Russell H; Elder J; Shah S; Carty C; Tan Z
    Transl Vis Sci Technol; 2023 Aug; 12(8):13. PubMed ID: 37578427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.
    Kıran Yenice E; Petriçli İS; Kara C
    Int Ophthalmol; 2023 Jul; 43(7):2197-2202. PubMed ID: 36522564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
    Morrison D; Shaffer J; Ying GS; Binenbaum G;
    J AAPOS; 2018 Apr; 22(2):128-133. PubMed ID: 29548840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External Validation of a Retinopathy of Prematurity Screening Model Using Artificial Intelligence in 3 Low- and Middle-Income Populations.
    Coyner AS; Oh MA; Shah PK; Singh P; Ostmo S; Valikodath NG; Cole E; Al-Khaled T; Bajimaya S; K C S; Chuluunbat T; Munkhuu B; Subramanian P; Venkatapathy N; Jonas KE; Hallak JA; Chan RVP; Chiang MF; Kalpathy-Cramer J; Campbell JP
    JAMA Ophthalmol; 2022 Aug; 140(8):791-798. PubMed ID: 35797036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
    Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
    Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.
    Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I
    Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomical and refractive outcomes in patients with treated retinopathy of prematurity.
    Lolas M; Tuma A; Zanolli M; Agurto R; Stevenson R; Ossandón D
    Arch Soc Esp Oftalmol; 2017 Oct; 92(10):472-476. PubMed ID: 28624314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey.
    Gunay M; Celik G; Tuten A; Karatekin G; Bardak H; Ovali F
    PLoS One; 2016; 11(8):e0161692. PubMed ID: 27548628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9.
    Laveti V; Balakrishnan D; Rani PK; Mohamed A; Jalali S
    Int Ophthalmol; 2020 Dec; 40(12):3539-3545. PubMed ID: 32776299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
    Morrison SL; Dukhovny D; Chan RVP; Chiang MF; Campbell JP
    JAMA Ophthalmol; 2022 Apr; 140(4):401-409. PubMed ID: 35297945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?
    Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G
    Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
    Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity: Anatomic Outcomes and Influencing Factors.
    Huang Q; Zhang Q; Fei P; Xu Y; Lyu J; Ji X; Peng J; Li YA; Zhao P
    Ophthalmology; 2017 Aug; 124(8):1156-1164. PubMed ID: 28412066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of intravitreal bevacizumab for the treatment of retinopathy of prematurity: a single-center retrospective review.
    Frosini S; Franco F; Vicini G; Nicolosi C; Varriale G; Dani C; Virgili G; Giansanti F
    J Matern Fetal Neonatal Med; 2022 Sep; 35(17):3337-3342. PubMed ID: 32933350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.